AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12489063 — intervention group
Group type: EXPERIMENTAL
Intervention: diet plus LIFE (N = 21)
Number of subjects: 39
Study 9785782 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline group (n = 15) - received saline 10 ml injected through an epidural catheter 20 min after spinal anesthesia
Number of subjects: 30
Study 9785782 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 15) - received 2% lidocaine 3 ml with 0.4% tetracaine injected into the subarachnoid space; saline was not injected into the epidural space
Number of subjects: 30
Study 8585716 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir 1.0 mg/kg intravenous infusion
Number of subjects: 28
Study 8585716 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir 3.0 mg/kg intravenous infusion
Number of subjects: 28
Study 8585716 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir 1.0 mg/kg/day for 22 days
Number of subjects: 28
Study 8585716 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir 3.0 mg/kg/day for 22 days
Number of subjects: 28
Study 8585716 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir 3.0 mg/kg oral dose
Number of subjects: 28
Study 8585716 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir 3.0 mg/kg subcutaneous dose
Number of subjects: 28
Study 2198088 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysaccharide K (PSK)
Number of subjects: 111
Study 2198088 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 216045 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline treatment
Number of subjects: 6
Study 31186150 — intervention group
Group type: EXPERIMENTAL
Intervention: ARA‐25 (25 g ARA/100 kcal, no added prebiotic blend)
Number of subjects: 80
Study 31186150 — intervention group
Group type: EXPERIMENTAL
Intervention: PDX/GOS (34 mg ARA/100 kcal, with prebiotic blend)
Number of subjects: 80
Study 31186150 — intervention group
Group type: COMPARATOR
Intervention: Control (34 mg ARA/100 kcal, no added prebiotic blend)
Number of subjects: 80
Study 25284356 — intervention group
Group type: EXPERIMENTAL
Intervention: Nexplanon® removal
Number of subjects: 0
Study 23376335 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 0
Study 23376335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21729443 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-over, zigzag neopharyngoplasty (group two)
Number of subjects: 30
Study 21729443 — intervention group
Group type: COMPARATOR
Intervention: Pharyngoesophageal myotomy (group one)
Number of subjects: 30
Study 19774805 — intervention group
Group type: EXPERIMENTAL
Intervention: FMR+TS
Number of subjects: 101
Study 19774805 — intervention group
Group type: COMPARATOR
Intervention: FMR
Number of subjects: 101
Study 16681586 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 5% 5-FU ointment
Number of subjects: 80
Study 16681586 — intervention group
Group type: COMPARATOR
Intervention: Placebo aqueous cream
Number of subjects: 80
Study 14713798 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 cc 2% lidocaine gel administered intrarectally 10 minutes before biopsy
Number of subjects: 328
Study 14713798 — intervention group
Group type: COMPARATOR
Intervention: 10 cc 1% lidocaine under ultrasound guidance as 2 periprostatic injections of 5 cc 5 minutes prior to biopsy
Number of subjects: 328
Study 11704133 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal hydrolaparoscopy (THL) combined with minihysteroscopy
Number of subjects: 23
Study 11704133 — intervention group
Group type: COMPARATOR
Intervention: Hysterosalpingography (HSG)
Number of subjects: 23
Study 11704133 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal hydrolaparoscopy (THL)
Number of subjects: 23
Study 11704133 — intervention group
Group type: EXPERIMENTAL
Intervention: Minihysteroscopy
Number of subjects: 23
Study 9863105 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligustrazine (LGT) administered by intravenous drip before occlusion and immediately after release
Number of subjects: 16
Study 9863105 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 16
Study 7943837 — intervention group
Group type: COMPARATOR
Intervention: Without isoflurane in a darkened, quiet room
Number of subjects: 10
Study 7943837 — intervention group
Group type: EXPERIMENTAL
Intervention: At 0.1 MAC isoflurane in a darkened room
Number of subjects: 10
Study 7943837 — intervention group
Group type: EXPERIMENTAL
Intervention: Without isoflurane with audiovisual input
Number of subjects: 10
Study 7943837 — intervention group
Group type: EXPERIMENTAL
Intervention: At 0.1 MAC isoflurane with audiovisual input
Number of subjects: 10
Study 3294815 — intervention group
Group type: EXPERIMENTAL
Intervention: trifluoperazine 1 mg b.i.d.
Number of subjects: 54
Study 3294815 — intervention group
Group type: COMPARATOR
Intervention: haloperidol 0.5 mg b.i.d.
Number of subjects: 54
Study 3294815 — intervention group
Group type: EXPERIMENTAL
Intervention: trifluoperazine
Number of subjects: 54
Study 3294815 — intervention group
Group type: COMPARATOR
Intervention: haloperidol
Number of subjects: 54
Study 31081360 — intervention group
Group type: EXPERIMENTAL
Intervention: Red orange juice supplementation (ROJS)
Number of subjects: 11
Study 31081360 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 11
Study 31220936 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 1644
Study 31220936 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1644
Study 27918976 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-oriented program (education classes, group discussions, home visit, telephone follow-up)
Number of subjects: 140
Study 27918976 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-oriented program
Number of subjects: 140
Study 27918976 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 140
Study 27918976 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher self-management scores
Number of subjects: 140
Study 25249470 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion-focused early intervention combining an emotion socialization parenting program with a child and school socio-emotional intervention
Number of subjects: 204
Study 25249470 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 204
Study 23468193 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 102
Study 23468193 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 102
Study 21703531 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval cycle training combined with strength training (40 minutes of interval cycle training + 20 minutes of strength training)
Number of subjects: 28
Study 21703531 — intervention group
Group type: COMPARATOR
Intervention: Interval training alone (40 minutes of interval cycle training)
Number of subjects: 28
Study 19224089 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (9 mg sublingually)
Number of subjects: 71
Study 16877596 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic-on-ceramic total hip replacement
Number of subjects: 28
Study 16877596 — intervention group
Group type: COMPARATOR
Intervention: Metal-on-metal total hip replacement
Number of subjects: 28
Study 15117042 — intervention group
Group type: EXPERIMENTAL
Intervention: ephedrine 70 microg/kg given 1 minute before induction
Number of subjects: 60
Study 15117042 — intervention group
Group type: COMPARATOR
Intervention: saline (control group) and midazolam 7.5 mg given orally 30‐60 minutes before induction
Number of subjects: 60
Study 11281386 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF-mobilized peripheral blood stem cell transplantation (BCT)
Number of subjects: 46
Study 11281386 — intervention group
Group type: COMPARATOR
Intervention: Bone marrow transplantation (BMT)
Number of subjects: 46
Study 9054279 — intervention group
Group type: EXPERIMENTAL
Intervention: Stavudine
Number of subjects: 822
Study 9054279 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine
Number of subjects: 822
Study 7951550 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy with insulin and fluid administration
Number of subjects: 26
Study 7951550 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic ketoacidosis patients (hyponatremia with hyperkalemia)
Number of subjects: 26
Study 7951550 — intervention group
Group type: EXPERIMENTAL
Intervention: Non‐ketotic hyperosmolar coma patients (hyponatremia with hyperkalemia)
Number of subjects: 26
Study 7951550 — intervention group
Group type: EXPERIMENTAL
Intervention: Non‐ketotic hyperosmolar coma patients (hypernatremia with hypokalemia)
Number of subjects: 26
Study 3038494 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bran + digoxin
Number of subjects: 30
Study 3038494 — intervention group
Group type: EXPERIMENTAL
Intervention: Ispaghula + digoxin
Number of subjects: 30
Study 3038494 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study 29243007 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone
Number of subjects: 38
Study 29243007 — intervention group
Group type: EXPERIMENTAL
Intervention: Televideo
Number of subjects: 38
Study 27241991 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish treatment once a month for 6 months
Number of subjects: 240
Study 27241991 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride film treatment once a month for 6 months
Number of subjects: 240
Study 27241991 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (control group)
Number of subjects: 240
Study 24239143 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Benefit Index (PBI-L)
Number of subjects: 82
Study 23793167 — intervention group
Group type: EXPERIMENTAL
Intervention: Er-Xian decoction (EXD)
Number of subjects: 108
Study 23793167 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 19945106 — intervention group
Group type: EXPERIMENTAL
Intervention: Calligraphy handwriting
Number of subjects: 90
Study 19945106 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation and guided imagery training
Number of subjects: 90
Study 19945106 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 17828786 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting oxybutynin
Number of subjects: 14
Study 17828786 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine
Number of subjects: 14
Study 17828786 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 11986101 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 118
Study 11986101 — intervention group
Group type: COMPARATOR
Intervention: Laser photocoagulation
Number of subjects: 118
Study 9561981 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole
Number of subjects: 959
Study 9561981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 959
Study 8282334 — intervention group
Group type: EXPERIMENTAL
Intervention: cilazapril (2.5 to 5 mg/d)
Number of subjects: 17
Study 8282334 — intervention group
Group type: COMPARATOR
Intervention: atenolol (50 to 100 mg/d)
Number of subjects: 17
Study 2498936 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg nicotine chewing gum
Number of subjects: 16
Study 2498936 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg nicotine chewing gum
Number of subjects: 16
Study 2498936 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 16
Study 2498936 — intervention group
Group type: COMPARATOR
Intervention: Placebo chewing gum
Number of subjects: 16
Study 1156825 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education about psychiatric consultations
Number of subjects: 50
Study 1156825 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 50
Study 31041623 — intervention group
Group type: EXPERIMENTAL
Intervention: School support intervention for females
Number of subjects: 835
Study 31041623 — intervention group
Group type: EXPERIMENTAL
Intervention: School support intervention for males
Number of subjects: 835
Study 31041623 — intervention group
Group type: EXPERIMENTAL
Intervention: School support intervention
Number of subjects: 835
Study 28917657 — intervention group
Group type: EXPERIMENTAL
Intervention: ATRA plus danazol (10 mg twice daily + 200 mg twice daily)
Number of subjects: 93
Study 28917657 — intervention group
Group type: COMPARATOR
Intervention: Danazol (200 mg twice daily)
Number of subjects: 93
Study 25588847 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IMN)
Number of subjects: 58
Study 25588847 — intervention group
Group type: COMPARATOR
Intervention: Proximal tibial plating (PTP)
Number of subjects: 58
Study 23223674 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous renal replacement therapy
Number of subjects: 30
Study 23223674 — intervention group
Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 30
Study 21324455 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdose leuprolide acetate (LA) protocol
Number of subjects: 54
Study 21324455 — intervention group
Group type: COMPARATOR
Intervention: GnRH antagonist protocol with luteal phase E(2) patch
Number of subjects: 54
Study 19243357 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 90 mg after fasting
Number of subjects: 48
Study 19243357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 16954724 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (oral and intravenous dosing)
Number of subjects: 38
Study 16954724 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive therapy (oral or injectable)
Number of subjects: 38
Study 16954724 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (oral administration)
Number of subjects: 38
Study 16954724 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive therapy
Number of subjects: 38
Study 15159264 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous adjusted-dose unfractionated heparin (UFH)
Number of subjects: 720
Study 15159264 — intervention group
Group type: COMPARATOR
Intervention: Fixed-dose low-molecular-weight heparin (nadroparin)
Number of subjects: 720
Study 11566649 — intervention group
Group type: EXPERIMENTAL
Intervention: Red palm oil
Number of subjects: 90
Study 11566649 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower oil
Number of subjects: 90
Study 11566649 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional diet with dark-green leafy vegetables)
Number of subjects: 90
Study 9032176 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental antigen challenge (SAC) on Days 1 and 2
Number of subjects: 3
Study 9032176 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental antigen challenge (SAC) on Day 2
Number of subjects: 3
Study 9032176 — intervention group
Group type: EXPERIMENTAL
Intervention: Eosinophil-active cytokines (IL-5, GM-CSF, IL-3)
Number of subjects: 3
Study 9032176 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 3
Study 8344680 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 i.v. cyclophosphamide pulses until remission
Number of subjects: 21
Study 8344680 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 i.v. cyclophosphamide pulses
Number of subjects: 21
Study 31435964 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of alfaxalone (10 mg/kg)
Number of subjects: 20
Study 31435964 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of alfaxalone (10 mg/kg)
Number of subjects: 20
Study 30109955 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based interventions promoting child sleep (20% of interventions)
Number of subjects: 119
Study 30109955 — intervention group
Group type: COMPARATOR
Intervention: Interventions targeting diet
Number of subjects: 119
Study 30109955 — intervention group
Group type: COMPARATOR
Intervention: Interventions targeting physical activity
Number of subjects: 119
Study 30109955 — intervention group
Group type: COMPARATOR
Intervention: Interventions targeting media use
Number of subjects: 119
Study 30109955 — intervention group
Group type: COMPARATOR
Intervention: Interventions implemented in clinics
Number of subjects: 119
Study 30109955 — intervention group
Group type: COMPARATOR
Intervention: Interventions implemented in home-based settings
Number of subjects: 119
Study 30109955 — intervention group
Group type: COMPARATOR
Intervention: Interventions conducted in the United States
Number of subjects: 119
Study 30109955 — intervention group
Group type: COMPARATOR
Intervention: Randomized controlled design
Number of subjects: 119
Study 30109955 — intervention group
Group type: EXPERIMENTAL
Intervention: Education on sleep hygiene
Number of subjects: 119
Study 30109955 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive feeding practices
Number of subjects: 119
Study 30109955 — intervention group
Group type: EXPERIMENTAL
Intervention: Limiting media use
Number of subjects: 119
Study 30109955 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime routines
Number of subjects: 119
Study 30109955 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of children's sleep by parent report
Number of subjects: 119
Study 27009831 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclatasvir (DCV) 60 mg once daily plus Asunaprevir (ASV) 100 mg twice daily for 12 weeks
Number of subjects: 186
Study 24677417 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor test (CPT)
Number of subjects: 25
Study 24677417 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischaemic muscle pain (ISC)
Number of subjects: 25
Study 24677417 — intervention group
Group type: COMPARATOR
Intervention: Conditioning stimulus (CPT or ISC)
Number of subjects: 25
Study 22580860 — intervention group
Group type: EXPERIMENTAL
Intervention: IV fentanyl PCA after SA
Number of subjects: 90
Study 22580860 — intervention group
Group type: EXPERIMENTAL
Intervention: IV fentanyl PCA after GA
Number of subjects: 90
Study 22580860 — intervention group
Group type: EXPERIMENTAL
Intervention: IV tramadol PCA after GA
Number of subjects: 90
Study 22580860 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study 20542780 — intervention group
Group type: EXPERIMENTAL
Intervention: FX06
Number of subjects: 234
Study 20542780 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study 18583470 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg by mouth daily
Number of subjects: 27
Study 16525672 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-bound polysaccharide K (PSK)
Number of subjects: 0
Study 16525672 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 12705565 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep restriction (1 hour less sleep)
Number of subjects: 77
Study 12705565 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep extension (1 hour more sleep)
Number of subjects: 77
Study 10871461 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard assay for activated protein C resistance
Number of subjects: 20
Study 10871461 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified assay for activated protein C resistance
Number of subjects: 20
Study 10871461 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancies of women with preexisting activated protein C resistance
Number of subjects: 20
Study 10871461 — intervention group
Group type: EXPERIMENTAL
Intervention: Allele-specific polymerase chain reaction analysis
Number of subjects: 20
Study 8706037 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of live births
Number of subjects: 0
Study 8706037 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms in the breast revealed on direct questioning
Number of subjects: 0
Study 1550275 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 ml propofol (10 mg)
Number of subjects: 50
Study 1550275 — intervention group
Group type: COMPARATOR
Intervention: 1 ml placebo (Intralipid)
Number of subjects: 50
Study 1550275 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary dose of 10 mg propofol (for treatment failures in placebo group)
Number of subjects: 50
Study 1550275 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol group
Number of subjects: 50
Study 1550275 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 3897722 — intervention group
Group type: EXPERIMENTAL
Intervention: 330 mg of acetylsalicylic acid (aspirin) plus 75 mg of dipyridamole three times daily
Number of subjects: 125
Study 30838188 — intervention group
Group type: EXPERIMENTAL
Intervention: Blindfold group (BG)
Number of subjects: 48
Study 30838188 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 48
Study 29303446 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent ipilimumab
Number of subjects: 72
Study 29303446 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent ipilimumab with SRS dose ≥ 20 Gy
Number of subjects: 72
Study 29303446 — intervention group
Group type: EXPERIMENTAL
Intervention: Any ipilimumab
Number of subjects: 72
Study 29303446 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ipilimumab)
Number of subjects: 72
Study 29303446 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall incidence of pathologically confirmed radiation necrosis (RN)
Number of subjects: 72
Study 26880541 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support intervention (multimodal including counselling by a trained nurse)
Number of subjects: 0
Study 26880541 — intervention group
Group type: COMPARATOR
Intervention: Standard decision-making support (control group)
Number of subjects: 0
Study 25189328 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational programme based on the Health Belief Model (HBM), consisting of four 1-hour sessions twice per week
Number of subjects: 120
Study 25189328 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 120
Study 23181955 — intervention group
Group type: EXPERIMENTAL
Intervention: Yang-style Tai Chi exercise programme (3 times a week for 8 weeks)
Number of subjects: 58
Study 23181955 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 58
Study 19147137 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment (not specified)
Number of subjects: 44